Conceptual Development of Industrial Biotechnology for Commercial Production of Vaccines and Biopharmaceuticals
Basanta Kumara Behera
2023 ж. нау. · Elsevier
Электрондық кітап
310
бет
family_home
Жарамды
info
reportРейтингілер мен пікірлер тексерілмеген. Толығырақ
Осы электрондық кітап туралы ақпарат
Conceptual Development of Industrial Biotechnology for Commercial Production of Biopharmaceuticals and Vaccines provides insights on how to bring sustainability into biologic drug production. The cumulative facts and figures within in the book are helpful to promoters in monitoring value chain transfer process of super quality biologics for better return in profits. In addition, this is a useful reference for students, researchers and scientists in biotechnology, pharmaceutical science, medical sciences, and the R&D division of biotechnology-based industries. Conceptual development of biotechnology has taken new avenues with the integration of medical sciences, physical science, and engineering, hence this is a timely source. The current global market for vaccines, especially COVID-19, is tremendous. Bivalent oral polio vaccine, diphtheria, tetanus-containing, and measles-containing vaccines have a high demand internationally and recombinant DNA technology and protein engineering are helpful in the production of quality bio-products. - Informs how biotechnology and pharmaceutical industries act as central pillars for the stable production of value-added biological drugs and vaccines from genetically engineered suitable vectors like microbe or cell lines from animals, mammals or plants - Highlights various traditional and modern techniques used for improvising the quality of suitable vectors to produce biologic drugs and vaccines under GMP manufacturing facilities - Provides updated information on the latest microchip-based bioreactors, disposable bag bioreactors, and animal systems as bioreactors to produce biologic drugs like Smart Biomolecules (next generation therapeutics), Bio-similar drugs, Bio-betters, and antibody-drug conjugates - Explains how the closed bioreactors with proper mechanical amendments are used for vaccine production
Авторы туралы
Dr. Basanta Kumara Behera was a Professor of Biotechnology at three distinguished Indian universities, where he taught and conducted research at the post-graduate level on medical biotechnology, biopharmaceutical, microbial process development, drug designing, bio-energy management, and biomass processing technology since 1978. In 2009, he joined an MNC company as an advisor for specialty chemicals production and drug design through microbial process technology. He is associated with national and international companies as a technical advisor to produce biopharmaceuticals under cGMP norms. Dr. Behera has authored and edited books with various publishers worldwide.
Осы электрондық кітапты бағалаңыз.
Пікіріңізбен бөлісіңіз.
Ақпаратты оқу
Смартфондар мен планшеттер
Android және iPad/iPhone үшін Google Play Books қолданбасын орнатыңыз. Ол аккаунтпен автоматты түрде синхрондалады және қайда болсаңыз да, онлайн не офлайн режимде оқуға мүмкіндік береді.
Ноутбуктар мен компьютерлер
Google Play дүкенінде сатып алған аудиокітаптарды компьютердің браузерінде тыңдауыңызға болады.
eReader және басқа құрылғылар
Kobo eReader сияқты E-ink технологиясымен жұмыс істейтін құрылғылардан оқу үшін файлды жүктеп, оны құрылғыға жіберу керек. Қолдау көрсетілетін eReader құрылғысына файл жіберу үшін Анықтама орталығының нұсқауларын орындаңыз.
